The acceptability of an injectable, once-a-month male contraceptive in China

Contraception

Volumn 73, Issue 5, 2006, Pages 548-553

  Zhang, Liying ^a   Shah, Iqbal H ^b   Liu, Yunrong ^a   Vogelsong, Kirsten M ^b   Zhang, Lihong ^c  

^a NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Shandong Institute for Family Planning   (China)

Author keywords

Acceptability; China; Male contraceptive; Multicenter study; Testosterone undecanoate

Indexed keywords

CONTRACEPTIVE AGENT; TESTOSTERONE UNDECANOATE;

ARTICLE; ATTITUDE; CHINA; CONTRACEPTION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INTERVIEW; MALE; NORMAL HUMAN; QUESTIONNAIRE; SEMEN ANALYSIS; WELLBEING;

ANTISPERMATOGENIC AGENTS; ATTITUDE; CHINA; COMMUNICATION; DECISION MAKING; FEMALE; HUMANS; INJECTIONS; MALE; MOTIVATION; PATIENT ACCEPTANCE OF HEALTH CARE; TESTOSTERONE;

EID: 33646070245     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.10.012     Document Type: Article

References (4)

1. National Population and Family Planning Commission of China. Statistical Report of Population and Family Planning, 2000-2003. http://www.npfpc.gov.cn/data/data-20041014-1.htm [Accessed on July 8, 2005]
2. Gu Y.Q., Wang X.H., Xu D., et al. A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men. J Clin Endocrinol Metab 88 (2003) 562-568
3. Tu P., Qiu S.H., Fang H.M., and Herbert L.S. Acceptance, efficacy, and side effects of Norplant implants in four counties in North China. Stud Fam Plann 28 (1997) 122-131
4. Liu Y.R. The factors influencing male participation into family planning in China. In: Liu Y. (Ed). Study on men's participation in family planning (1998), China Population Publish House, Beijing 1-30